
Dynamk Capital
North America, New York, United States, New York
Description
Venture fund focused entirely on Life Sciences Industrials - tools, technologies and services fundamental to biopharma.
Investor Profile
Dynamk Capital has made 19 investments, with 0 in the past 12 months and 74% as lead.
Stage Focus
- Series A (58%)
- Seed (21%)
- Series B (16%)
- Series Unknown (5%)
Country Focus
- United States (84%)
- Norway (5%)
- Canada (5%)
- Switzerland (5%)
Industry Focus
- Biotechnology
- Medical
- Life Science
- Health Care
- Artificial Intelligence (Ai)
- Therapeutics
- Manufacturing
- Medical Device
- Bioinformatics
- Machine Learning
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.